NIH-funded research R21 grant

Investigating how neuroactive steroids affect Tourette syndrome

Official title: Exploring the role of neuroactive steroids in Tourette syndrome

Funded at University of Utah · NIH-10656348 · Data updated 2026-11-12

This study is looking at how certain brain chemicals might affect the symptoms of Tourette syndrome, especially in boys, and how stress can make tics worse, with the hope of finding new ways to help manage the condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startJuly 1, 2022
Project endJune 30, 2025
Funding year2023
Award (this year)$196,719
NIH project number5R21NS125654-02
Project IDNIH-10656348 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Tourette syndrome, particularly those experiencing significant tic symptoms.

Less likely to help

Patients without a diagnosis of Tourette syndrome or those whose symptoms are well-managed may not benefit from this research.

What this research studies

This research explores the biological mechanisms behind Tourette syndrome (TS), focusing on how neuroactive steroids may influence the disorder's symptoms. Researchers will examine the role of these steroids in relation to the male predominance of TS and how stress impacts tic expression. By studying animal models, the team aims to uncover how specific neuroactive steroids, like DHEA and allopregnanolone, affect tic behavior and the brain's ability to manage these tics. The findings could lead to a better understanding of TS and potential new treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for Tourette syndrome, enhancing the quality of life for affected individuals.

How similar studies have gone: While the specific focus on neuroactive steroids in TS is relatively novel, previous studies have shown promise in understanding the biological underpinnings of similar neurodevelopmental disorders.

Where this research is happening

  • University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Bortolato, Marco — University of Utah
  • Study coordinator: Bortolato, Marco

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.